Diabeloop, a pioneer in automated insulin delivery, will collaborate with Novo Nordisk to integrate DBL-4pen, Diabeloop’s self-learning algorithm for MDI therapy, with Novo Nordisk’s connected and reusable insulin pens, NovoPen 6 and NovoPen Echo Plus with DBL-4pen. DBL-4pen is a self-learning basal and bolus recommendation app for people with Type 1 and Type 2 diabetes who take multiple daily insulin injections (MDI). NovoPen 6 and NovoPen Echo Plus are connected pens with a d...